Health
Study: Stereotactic body radiotherapy can be safely used to treat patients with multiple metastases – News-Medical.net
The first National Institutes of Health National Cancer Institute-funded clinical study examining stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic…
The first National Institutes of Health (NIH) National Cancer Institute (NCI)-funded clinical study examining stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic breast, prostate, and non-small cell lung (NSCLC) cancers displayed evidence that SBRT can be safely used to treat patients who have multiple metastases. These results were recently published in JAMA Oncology.
The results of the Phase I NRG-BR001 trial, conducted by the NCI National Clinical Trials Network group NRG…
-
Business24 hours agoHow to retire in your 50s with ASX shares
-
General24 hours agoFood and garden organic waste bin system on verge of collapse across WA’s South West
-
Noosa News22 hours agoBig Brother’s Mike Goldman reveals what saved his life after waking up to find Brisbane home engulfed in fire
-
Noosa News20 hours agoBroncos’ Adam Reynolds confident of NRL finals return, Raiders’ Josh Papalii injured